ArticleEuropean thyroid journal2026
Suspected track-site seeding as an isolated deep SH-SCM papillary thyroid carcinoma lesion years after TOETVA.
Article in European thyroid journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary thyroid carcinoma (PTC) has an excellent prognosis, and the transoral endoscopic thyroidectomy vestibular approach (TOETVA) is increasingly used in selected low-risk patients. However, creation of long working tunnels may predispose to tract-related tumor seeding, and deep tract recurrences have rarely been reported. Case presentation: A 29-year-old woman underwent right hemithyroidectomy with central neck dissection via TOETVA in 2016 for a 3 cm encapsulated PTC with one metastatic central node. Serial ultrasounds over five years showed no disease before a three-year lapse in follow-up. In 2024, ultrasound detected a new 1.1 cm hypoechoic nodule anterior to the left sternohyoid; by late 2025, it had enlarged to about 2 cm and cytology confirmed PTC. Computed tomography demonstrated an enhancing mass in the deep left sternohyoid-sternocleidomastoid (SH-SCM) intermuscular compartment, noncontiguous with the thyroid bed and outside usual nodal chains. The lesion was excised en bloc via a supraclavicular approach, and histology again showed PTC without lymph node architecture. Review of the index TOETVA video revealed deviation of the vestibular tunnel into the SH-SCM space, where dissected central nodal tissue, including the metastatic node, had been temporarily placed. Conclusions: This isolated PTC recurrence in the deep SH-SCM plane, detected about eight years after TOETVA, is highly suggestive of delayed tract-related implantation with a latency of at least five years, although causality cannot be proved. The case emphasizes strict adherence to recommended dissection planes, careful handling of lymph node specimens, and consideration of extended, access-tract-oriented ultrasound surveillance in young patients undergoing TOETVA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.